June 20, 2013     Japanese 
  JCN 
	  Network - Home
JCN Newswire
  Home  |  Companies  | Annual Reports  |  CSR  | News Alerts     
 
Share:
SS Pharmaceutical to Market New Urination Disorder Drug
 

Tokyo, Jan 27, 2006 (JCN) - SS Pharmaceutical announced on January 26 that it will begin distributing over-the-counter drug BEARBERIX through pharmacies and drugs stores nationwide on February 1.

The new product, which contains an extract of bearberry leaves as an active ingredient, helps alleviate urinary symptoms such as discomfort when urinating and a constant urge to urinate.

This granule drug can be taken by dissolving it in water. One unit containing 30 packs is available at 3,150 yen ($27). The company aims to achieve 200 million yen ($1.7 mil) in sales in the first year.

By Aki Tsukioka Contributor

Copyright © 2013 JCN. All rights reserved. A division of Japan Corporate News Network KK.


 Company Profile |   Print  |   Alerts
ACN Newswire

 Recent  SS Pharmaceutical News  
  SS Pharmaceutical to Market New Urination Disorder Drug  (Jan 27, 2006)
  SS Pharmaceutical to Market New Version of Its OTC Vitamin B Preparation Lolan BB  (July 26, 2005)
  SS Pharmaceutical Completes Transfer of Its Ethical Drug Business to Hisamitsu Pharmaceutical  (Apr 4, 2005)
  SS Pharmaceutical to License Ajinomoto to Distribute Harmonic Enteral Nutrition  (Jan 24, 2005)
  SS Pharmaceutical's Two New OTC Anti-inflammatory Analgesic Poultices to Hit Market  (Dec 10, 2004)
  SS Pharmaceutical to Market New Cold Remedy  (Oct 6, 2004)
  CMIC to Forge Partnership with SSP's Wholly Owned Subsidiary IAM  (July 23, 2004)
  SSP to Transfer Ethical Drug Business to Hisamitsu Pharmaceutical in April 2005  (May 25, 2004)
  SSP and Mepha Jointly Develop Diclofenacnatrium-contained Poultice  (Nov 12, 2003)
  IBM's Large-scale e-marketing System Up and Running at SSP
 (May 2, 2002)


 
CSR Report Download
Annual Reports

  More >>    
Most Popular


About JCN | Privacy Policy | Terms of Use | JCN Network (日本語)